Publications by authors named "S Zwirner"

Claim this Profile
D
Discovery of the First Highly Selective 1,4-dihydropyrido[3,4-]pyrazin-3(2H)-one MKK4 Inhibitor.
Leon Katzengruber, Pascal Sander, Stefan Zwirner, Alexander Rasch, Eric Eberlein

J Med Chem· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A "Ligand First" Approach toward Selective, Covalent JNK2/3 Inhibitors.
Valentin R Wydra, Nicole Plank, Stefan Zwirner, Roland Selig, Alexander Rasch

J Med Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assisted Parkinsonism Diagnosis Using Multimodal MRI-The Role of Clinical Insights.
Tobias Meindl, Alexander Hapfelmeier, Tobias Mantel, Angela Jochim, Jonas Deppe, Silke Zwirner

Brain Behav· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure.
Stefan Zwirner, Anan A Abu Rmilah, Sabrina Klotz, Bent Pfaffenroth, Philip Kloevekorn

Cell· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancer.
Ramona Rudalska, Jule Harbig, Marteinn T Snaebjornsson, Sabrina Klotz, Stefan Zwirner

Nat Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis